Specify a stock or a cryptocurrency in the search bar to get a summary
Mankind Pharma Ltd
MANKINDMankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials ayurvedic products, packing materials, bulk drugs, and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services. Mankind Pharma Limited was founded in 1986 and is based in New Delhi, India. Address: 262, Okhla Industrial Estate, New Delhi, India, 110 020
Analytics
WallStreet Target Price
187 191.07 INRP/E ratio
49.4782Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures MANKIND
Dividend Analytics MANKIND
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History MANKIND
Stock Valuation MANKIND
Financials MANKIND
Results | 2019 | Dynamics |